Partnership Overview Sunnybrook-based start-up Vasomune Therapeutics has announced an expanded collaboration with the Japanese biopharma company AnGes to broaden the indications for their vascular damage treatment candidate. The agreement will extend the reach of the collaboration beyond its initial scope, enabling further development and validation across additional vascular conditions. The expanded partnership comes with a…